Are coronary event rates declining slower in women than in men – evidence from two population-based myocardial infarction registers in Finland? by Lehto, Hanna-Riikka et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Cardiovascular Disorders
Open Access Research article
Are coronary event rates declining slower in women than in men – 
evidence from two population-based myocardial infarction 
registers in Finland?
Hanna-Riikka Lehto1, Seppo Lehto2, Aki S Havulinna3, Matti Ketonen4, 
Aapo Lehtonen5, Y Antero Kesäniemi6, Juhani Airaksinen1, Veikko Salomaa*3 
for the FINAMI Study Group
Address: 1Turku University Hospital, Turku, Finland, 2Kuopio University Hospital, Kuopio, Finland, 3KTL – National Public Health Institute, 
Mannerheimintie 166, FI-00300 Helsinki, Finland, 4North Karelia Central Hospital, Joensuu, Finland, 5Turku Town Hospital, Turku, Finland and 
6Oulu University Hospital and Biocenter Oulu, Oulu, Finland
Email: Hanna-Riikka Lehto - hrleht@utu.fi; Seppo Lehto - seppo.lehto@kuh.fi; Aki S Havulinna - aki.havulinna@ktl.fi; 
Matti Ketonen - matti.ketonen@pkssk.fi; Aapo Lehtonen - aapleh@utu.fi; Y Antero Kesäniemi - antero.kesaniemi@oulu.fi; 
Juhani Airaksinen - juhani.airaksinen@tyks.fi; Veikko Salomaa* - veikko.salomaa@ktl.fi
* Corresponding author    
Abstract
Background: Studies have suggested that the prevention and treatment of coronary heart disease
may not have been as effective in women as in men. Therefore, we aimed to examine whether the
incidence, attack rate and mortality of myocardial infarction (MI) events have declined less in
women than in men.
Methods:  Two large population-based MI registers, the FINAMI register and the Finnish
Cardiovascular Disease Register (CVDR) were used for comparing the event rates among men and
women aged ≥35 years in two time periods, 1994–1996 and 2000–2002.
Results: In the FINAMI register a total of 5,252 events were recorded in men and 4,898 in women.
Corresponding numbers in the CVDR were 78,709 and 70,464. Both FINAMI and CVDR data
suggested smaller declines in incidence and attack rate of MI events in women than in men. In
CVDR data the decline in mortality was also smaller in women than in men, while in FINAMI data
this difference did not reach statistical significance. In the large CVDR data set, negative binomial
regression models revealed smaller declines in incidence (p = 0.006), attack rate (p = 0.008) and
mortality (p = 0.04) in women than in men aged <55 years. In persons ≥55 years no difference was
observed between women and men.
Conclusion: The incidence and attack rate of MI events have declined less in women aged <55
than in men of similar age. In older persons no significant differences were observed. Further
studies are warranted to find out the reasons why the development has been less favourable for
young women than for men.
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Background
The age-standardized mortality due to coronary heart dis-
ease (CHD) has declined during the past decades in west-
ern countries [1,2]. However, CHD still remains a major
cause of death in both genders across the developed
world. Traditionally, women are considered to be pro-
tected from CHD and myocardial infarction (MI), espe-
cially during the fertile age. This protection is known to
fade after the menopause and with ageing the levels of
common CHD risk factors are increasing more steeply in
women than in men, rendering older women susceptible
to MI and other cardiovascular diseases [3]. On the other
hand, a large study has suggested that in particular
younger women are at increased risk of poor outcome
after an MI event [4].
The incidence of MI has decreased especially in working-
aged men and increasing incidence rates have been
reported in older women [5,6]. There are several causes for
concern regarding the CHD event trends and risk factor
trends in women. First, in several countries, including Fin-
land, the prevalence of smoking has clearly declined
among men, whereas no decline or even an increasing
trend has been observed in women [7]. Second, the prev-
alence of type 2 diabetes is rapidly increasing and it is
known to be a stronger risk factor for CHD in women than
in men [8]. Furthermore, there is some evidence that the
treatment of symptomatic CHD may have been less active
in women than in men [9]. Recently, the American Heart
Association and the European Society of Cardiology have
focused special attention on women's cardiovascular dis-
ease [10,11]. The rationale is that the cardiovascular risk
may have been underestimated in women, which in turn
may have led to insufficient prevention and treatment
efforts in women.
Given the less favourable development in risk factors and
treatment of CHD among women than among men, we
hypothesized that the CHD event trends may have devel-
oped less favourably in women than in men. We used data
from two large Finnish population-based MI registers to
examine, whether the incidence, attack rate, and mortality
of MI events have declined less in women than in men.
Since we have shown previously that the adoption of tro-
ponins as the main markers of myocardial injury may
have caused a bigger increase in the MI diagnoses among
women than among men, we compared two time periods
1994–1996 (before the adoption of troponins) and
2000–2002 (after the adoption of troponins) [12]. We
further examined, whether the possible differences are
modified by the age group.
Methods
MI registers and case finding
We used data from two large population-based MI regis-
ters, the FINAMI register and the Finnish cardiovascular
disease register (CVDR). Both have been described previ-
ously in detail [13,14].
The FINAMI register aimed to evaluate all events sus-
pected to be a MI or CHD death among permanent resi-
dents of the four study areas. The data collection period of
the register was 10 years and the geographical areas cov-
ered were the town of Turku in southwestern Finland, the
town of Kuopio in eastern Finland, the town of Joensuu
and certain surrounding rural areas in the former province
of North Karelia and the town of Oulu in northwestern
Finland. Oulu joined in the project later and has collected
data for the years 1993, 1997, 1999, 2001 and 2002. The
combined population aged ≥35 of the FINAMI areas is
~313,000.
The primary sources for case finding in the FINAMI regis-
ter were hospital admission diagnoses and death certifi-
cates of each area. Trained nurses, supervised by the
register physicians, collected the information from hospi-
tal documents, death certificates and autopsy reports. The
local registration teams sent their data to the coordinating
centre at the National Public Health Institute in Helsinki.
There the data were checked for logical errors. Annually,
the data were further cross-checked with the computer-
ized nationwide Causes-of-Death Register and the nation-
wide Hospital Discharge Register for completeness [14].
The CVDR has been compiled using data from country-
wide administrative registers [13]. Cardiovascular parts of
the nationwide Causes-of-Death Register and the nation-
wide Hospital Discharge Register were linked together on
the basis of the personal ID code. The resulting database
includes individual level data on all cardiovascular events
in Finland, which have led to hospitalisation or death dur-
ing the period 1991–2005. The summary tables and
methodological details are available in the Internet [15].
Both the FINAMI register and CVDR have been approved
by the Ethical Committee of the National Public Health
Institute.
Diagnostic classification
In the FINAMI register, the events were classified on the
basis of symptoms, ECG-, and biomarker findings and
possible autopsy results as suggested in the American
Heart Association Scientific Statement of 2003 [16]. Defi-
nite, probable, and possible MI events were combined
and included in the main analyses of the present study.
Sensitivity analyses as well as some other analyses were
carried out including also cases of unstable angina. TheBMC Cardiovascular Disorders 2007, 7:35 http://www.biomedcentral.com/1471-2261/7/35
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period of one event was 28 days, during which the most
severe findings were recorded. The biomarkers used in
each case were determined according to the usual prac-
tices of the hospital in question at each point in time. Tro-
ponins were gradually adopted in Finnish hospitals from
1997 onwards. The values of troponin T or troponin I
were classified as diagnostic, normal, or missing on the
basis of the limits given by the laboratory of the hospital
in question. The local register physician evaluated the rel-
evance of troponin elevations using all available clinical
information. If the troponin value was considered non-
relevant, it was taken as missing. The other biomarkers
were classified according to the principles of the WHO
MONICA Project.
Both the nationwide Causes of Death Register and the
nationwide Hospital Discharge Register use the Interna-
tional Classification of Disease (ICD) codes. The 10th ver-
sion (ICD-10) has been used in Finland since the 1st of
January 1996 when it replaced the previous ICD-9 ver-
sion. The calculation of event rates included non-fatal
hospitalisations for MI (ICD-9 diagnoses 410 and ICD-10
diagnoses I21–I22), and fatal events, which included
deaths with CHD (410–414 and I20–I25), cardiac arrest
(I46), sudden death for unknown reason (798, not 798A,
R96), or unwitnessed death (R98) as the underlying or
direct cause of death, or deaths with MI (410, I21–I22) as
the contributing cause of death. The CHD diagnoses in
the Finnish Causes of Death Register and the Hospital
Discharge Register have been recently validated [17]. The
time frame for one event in both registers was 28 days.
Definitions
Incident event means the first CHD event for that particu-
lar patient. In the FINAMI register, an event was consid-
ered as incident if the review of hospital records and other
documents did not reveal earlier clinically symptomatic
MI events in the patient's history. In the CVDR, the Hos-
pital Discharge Register was checked backwards for a fixed
period of seven years and if no hospitalisations for earlier
MIs were found, the event was considered as incident. The
attack rate included both incident and recurrent events,
taking the time frame into account. Mortality included
those events, which ended fatally within 28 days from the
beginning of symptoms. All events in persons aged 35 or
higher were included in the present analyses.
Statistical Methods
Coronary event rates were expressed per 100,000 persons
and age-standardized according to the direct method
using 5-year age groups and the European standard popu-
lation [18]. The annual population counts for the denom-
inators were obtained from the National Population
Information System. The 95% confidence intervals (CI)
for the event rates were calculated assuming Poisson dis-
tribution for the annual number of events
We compared the age adjusted rates in two time periods,
1994–1996 (before the adoption of troponins) and
2000–2002 (after the adoption of troponins), except for
the FINAMI area of Oulu for which the earlier time period
consisted of years 1993 and 1997 and the latter period
was 2001–2002. The regions were pooled. Comparisons
were done using 100,000 simulated Poisson-draws from
each age group and using direct age standardization, to
obtain representative samples of rates in men and women
for both time periods. The differences in rates were then
calculated directly from these samples, with symmetric
95% confidence intervals. To test the relative difference in
trends between men and women, the differences between
time periods in men and women were normalized by the
respective rates in the first time period.
In the CVD register, we compared the trends in event rates
in 1994–1996 and 2000–2002 between men and women
using negative binomial regression models, as Poisson
regression models showed overdispersion. In the models
of incidence, attack rate and mortality, we adjusted for age
in 5-year age-groups with gender interaction and com-
pared the trends using the effect of year with separate
interaction terms for women <55 years and women ≥55
years. We verified the absence of autocorrelation by check-
ing the autocorrelation functions of model residuals strat-
ified by sex and 5-year age group.
The distribution of MI events to different diagnostic cate-
gories between each gender and both time periods were
examined using chi-square tests. The statistical analyses
were carried out using SAS software, version 8 (SAS Insti-
tute Inc, Cary, NC, USA), and R-software, version 2.5.1
[19].
Results
In the FINAMI register there were altogether 4,586 (2,370
in men and 2,216 in women) CHD events in the first
study period and 5,564 (2,882 in men and 2,682 in
women) in the latter period (Table 1). In the CVDR there
were 72,699 CHD events (38,849 in men and 33,850 in
women) in the first period and 76,474 (39,860 in men
and 36,614 in women) in the latter period (Table 1).
In the FINAMI register, the incidence of first CHD events
among women was similar in both study periods (Fig. 1).
Among men, the average age-standardized incidence per
100,000 inhabitants per year was in the first period 721
(95% CI 683 – 759) and in the latter period it had
declined to 655 (624 – 687). In CVDR, the 95% CIs of the
incidence rates were narrow due to the large numbers. A
decline was observed in both genders: among womenBMC Cardiovascular Disorders 2007, 7:35 http://www.biomedcentral.com/1471-2261/7/35
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from 396 (391 – 401) to 373 (368 – 377) and among men
from 889 (879 – 899) to 796 (788 – 805). The attack rate
of all CHD events was also very similar in both study peri-
ods among women in the FINAMI register (Fig 1). In men,
however, a clear decline was observed: 1176 (1128 –
1224) in the first period and 1068 (1028 – 1109) in the
second period. In the CVD register, declines in the attack
rate of CHD events were observed in both genders: from
505 (499 – 511) to 478 (472 – 483) in women and from
1,101 (1,090 – 1,112) to 996 (986 – 1,006) in men. The
mortality rate declined in the FINAMI register among
women slightly from 281 (265 – 297) in the first period
to 254 (240 – 268) in the latter period (Fig. 1). In men,
however, a larger decline was seen: from 623 (588 – 660)
to 508 (480 – 537). In CVDR, the mortality declined
among women from 284 (280 – 288) to 244 (240 – 247).
Among men, the decline was from 615 (606 – 623) to 505
(497 – 512).
Differences between men and women in changes in the
MI event rates from the first to the second study period are
presented in Table 2. The declines in incidence were larger
in men than in women both in the FINAMI register and in
CVDR. The calculation of relative changes, normalized to
the starting level, also confirmed larger declines in men
than in women. Findings in the attack rate of all MI events
were similar as those in the incident events (Table 2). In
mortality, the data also suggested larger declines in men
than in women (Table 2). In the FINAMI register, how-
ever, the difference in relative change between men and
women did not reach statistical significance.
In the large CVDR data set, we analyzed the differences in
MI event trends between men and women using negative
binomial regression models. These models confirmed the
generally declining trend in all three indicators considered
(Table 3). The models further revealed that for all three
indicators the trends were significantly less favorable in
women aged <55 years than in men of similar age. No dif-
ferences were observed between men and women aged
≥55 years. Similar modelling in the FINAMI data pro-
duced results that were generally consistent with the find-
ings in the CVDR, but the year by gender by age group <55
interaction failed to reach statistical significance, probably
due to the small amount of MI events in women aged <55
years in the FINAMI data.
We further analyzed the distribution of MI events in dif-
ferent diagnostic categories in the FINAMI data, including
also cases of unstable angina, in both genders and in both
study periods. This cross-tabulation demonstrated a sub-
stantial increase in the proportion of definite MIs among
women: 40% in the first period and 64% in the second
period (Table 4). The proportion of definite MIs also
increased among men but the increase was somewhat
smaller than among women (from 54% to 75%). Con-
versely, the proportions of unstable angina, possible MI
and probable MI were all substantially reduced among
women.
Discussion
The incidence, attack rate and mortality of CHD events
have declined in Finland during the past decades. Consist-
Table 1: Numbers and Age-Ranges1 of Men and Women With Acute MI Events.
FINAMI2 CVDR3
1994–1996 2000–2002 1994–1996 2000–2002
Incident events
Number of Men 1451 1776 31435 31936
Age 67.8 (59.0 – 77.0) 69.0 (59.0 – 79.0) 68.7 (61.0 – 78.0) 70.1 (61.0 – 79.0)
Number of Women 1396 1717 26174 28109
Age 78.6 (73.0 – 85.0) 79.6 (74.0 – 87.0) 78.2 (72.0 – 85.0) 79.8 (75.0 – 87.0)
All events
Number of Men 2370 2882 38849 39860
Age 69.2 (62.0 – 78.0) 70.6 (62.0 – 79.0) 69.4 (62.0 – 78.0) 70.9 (63.0 – 80.0)
Number of Women 2216 2682 33850 36614
Age 78.8 (73.0 – 85.0) 80.2 (75.0 – 87.0) 78.4 (73.0 – 85.0) 80.2 (75.0 – 87.0)
Fatal events
Number of Men 1219 1300 21333 19828
Age 71.9 (65.0 – 80.0) 73.4 (66.0 – 82.0) 71.8 (65.0 – 80.0) 73.4 (66.0 – 82.0)
Number of Women 1274 1358 20082 19855
Age 81.0 (76.0 – 87.0) 82.6 (78.0 – 89.0) 80.5 (75.0 – 87.0) 82.6 (78.0 – 89.0)
1Age is given as mean and interquartile range in years.
2FINAMI = FINAMI register.
3CVDR = Finnish Cardiovascular Disease RegisterBMC Cardiovascular Disorders 2007, 7:35 http://www.biomedcentral.com/1471-2261/7/35
Page 5 of 9
(page number not for citation purposes)
Average age-standardized CHD incidence, mortality and attack rate per 100 000 inhabitants in the FINAMI and CVD Registers  in 1994–1996 and 2000–2002 Figure 1
Average age-standardized CHD incidence, mortality and attack rate per 100 000 inhabitants in the FINAMI 
and CVD Registers in 1994–1996 and 2000–2002. The error bars denote 95% CIs of the event rates.
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ent with other reports [1,2], our study showed declining
trends in both genders, except the incidence and attack
rate among women in the FINAMI Study. The declines
were generally smaller among women than among men.
The modelling approach suggested that especially the
trends in young women have been less favourable than in
men. In women aged ≥ 55 years the trends did not differ
from those in men.
An obvious question is whether the differences in MI
event trends between men and women reflect real occur-
rence of the disease or whether they reflect technical
changes in the diagnostics of MI events. We have shown
Table 2: Changes (95% CI) in MI Event Rates Between the Two Study Periods.
Change 95% CI
Incidence
FINAMI
Change in men -65.4 -114.0 – -16.1
Change in women 9.5 -14.9 – 33.9
Difference in relative1 change between men and women -0.1 -0.22 – -0.02
CVDR
Change in men -92.9 -106.1 – -79.6
Change in women -23.1 -30.0 – -16.4
Difference in relative1 change between men and women -0.05 -0.07 – -0.02
Attack Rate
FINAMI
Change in men -107.2 -170.6 – -43.4
Change in women 2.2 -27.7 – 32.2
Difference in relative1 change between men and women -0.1 -0.17 – -0.02
CVDR
Change in men -104.9 -119.6 – -90.1
Change in women -27.3 -34.8 – -19.9
Difference in relative1 change between men and women -0.04 -0.06 – -0.02
Mortality
FINAMI
Change in men -114.3 -161.0 – -68.6
Change in women -27.0 -48.0 – -5.7
Difference in relative1 change between men and women -0.09 -0.19 – 0.01
CVDR
Change in men -109.9 -120.9 – -98.9
Change in women -40.4 -45.7 – -35.0
Difference in relative1 change between men and women -0.04 -0.06 – -0.01
1 Relative compared with the level in the first period.
Table 3: Risk Ratios (95% CI) for Acute MI Events in the CVD Register.
Risk Ratio 95% CI P
Incidence
Year 0.98 0.97 – 0.99 < 0.0001
Gender by year interaction in age group < 55 years1 1.04 1.01 – 1.06 0.0062
Gender by year interaction in age group ≥55 years1 1.00 0.99 – 1.01 0.4675
Attack Rate
Year 0.98 0.97 – 0.99 < 0.0001
Gender by year interaction in age group < 55 years1 1.04 1.01 – 1.06 0.0081
Gender by year interaction in age group ≥55 years1 1.00 0.99 – 1.01 0.7434
Mortality
Year 0.96 0.95 – 0.97 < 0.0001
Gender by year interaction in age group < 55 years1 1.04 1.00 – 1.09 0.0368
Gender by year interaction in age group ≥55 years1 1.00 0.99 – 1.01 0.8144
1Gender by year interaction termed as [women + year] vs. othersBMC Cardiovascular Disorders 2007, 7:35 http://www.biomedcentral.com/1471-2261/7/35
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previously that the adoption of troponins has caused a
greater increase in MI diagnoses among women than
among men [12]. It is, however, unlikely that the adop-
tion of troponins could explain the gender by age group
interaction observed in the present study. Furthermore,
there was a significant gender difference in mortality
trends, suggesting a smaller decline in CHD mortality
among young women than among men. This difference
cannot be explained by troponins, since they play only a
minor role in the diagnostic classification of fatal events.
Although several population-based studies have shown
that the MI incidence and CHD mortality have declined in
both genders during the last two decades, only few reports
have specifically evaluated the gender difference in CHD
mortality and incidence declines [20,21]. From the Olm-
sted County, MN, USA, Roger et al have reported slower
declines in MI incidence and mortality among women
than among men during the time period of 1979–1994
[21,22]. Derby et al reported a smaller decline in all and
in out-of-hospital CHD death rates in women compared
to men in two south-eastern New England communities
[20]. Neither of these studies evaluated the MI incidence
rates and both studies collected their data prior to the
adoption of troponins. A more recent study containing
data up to 2003 reported a smaller annual decline in CVD
mortality in women compared to men [23]. However, no
separate analysis was performed to evaluate the gender
difference specifically in CHD mortality.
Our current study shows a smaller decline, or no decline
according to the FINAMI register, in acute CHD event inci-
dence in women compared to men. A decrease in the inci-
dence of CHD events is mainly considered to be due to
favourable risk factor development in the population.
Some favourable trends in major CHD risk factors have
been seen in Finland. The cholesterol levels have declined
during the past 25 years in both genders [24]. Blood pres-
sure levels and the treatment of elevated blood pressure
have improved approximately equally in both genders
[25]. Certain other major CHD risk factor developments
have been less favourable among women. The prevalence
of smoking has increased in women, especially in younger
women, whereas a clear decrease has been observed in
men [7]. Exposure to tobacco smoke is known to increase
more women's risk of CHD and first MI event compared
to men [26]. Accordingly, we can speculate that the
increased smoking among young women may be a partial
explanation for the present findings. Other possibilities
include obesity and diabetes, which have increased in
both genders, but diabetes is known to be a stronger risk
factor for CHD in women than in men [8].
Interestingly, the proportion of MI events classified as def-
inite increased in both genders, presumably due to the use
of troponins. This increase was larger in women than in
men so that in the first period men had 14.3 percentage
points more definite MIs than women, whereas in the lat-
ter study period this was 11.1 percentage points. This sug-
gests that the greater sensitivity of troponins may help in
finding those acute MIs where the patient presents to the
clinician with less obvious acute coronary symptoms,
which are known to be common among women [26-28].
The current data also revealed a gender difference in the
decline in CHD mortality. One possible cause for the
slower mortality decline in women could be a less favour-
able development in case fatality. The short-term case
fatality and incidence of recurrent events after an acute MI
have been reported to be higher in women compared to
men [29]. Traditionally, this higher case-fatality is
explained with older age and higher prevalence of hyper-
tension and diabetes among women. However, gender
difference in CHD mortality has also been apparent even
after adjustments for these factors [30]. The slower decline
in women's CHD mortality and higher case-fatality seen
among women may be due to differences in acute coro-
nary care. It has been reported that women are less often
admitted to coronary care unit and less likely to receive
thrombolysis or invasive revascularization procedures
[9,31].
Strengths and limitations
The strength of our study was that we obtained largely
similar results using two large population-based MI regis-
ters, the CVD and the FINAMI registers. The Finnish
CVDR is based on country-wide administrative data
including all coronary events in Finland. The standardiza-
tion is, however, somewhat limited. On the other hand,
the FINAMI data cover four mainly urban areas only, but
Table 4: Diagnostic Categories of MI Events in the FINAMI 
Register by Gender and Study Period
1994–1996 2000–2002
Definite n (%) n (%)
Men 948 (53.9) 1479 (74.7)
Women 756 (39.6) 1299 (63.6)
Probable
Men 195 (11.1) 53 (2.7)
Women 290(15.2) 113 (6.5)
Possible
Men 308 (17.5) 244 (12.3)
Women 350 (18.3) 285 (14.0)
Unstable Angina Pectoris
Men 308 (17.5) 204 (10.3)
Women 515 (27.0) 326 (16.0)
P < 0.0001, chi-square teBMC Cardiovascular Disorders 2007, 7:35 http://www.biomedcentral.com/1471-2261/7/35
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are collected by trained staff using standardized data col-
lection procedures.
Conclusion
The incidence and attack rate of MI events have declined
more slowly in women than in men in Finland. This
seemed to be due to the unfavorable development in
young women, while in the older women the declines
were similar as in men. Possible explanations include the
increased prevalence of smoking among young women,
and the technical changes in the diagnostics of MI,
induced by the adoption of troponins. Further studies are
warranted to find out the reasons why the development
has been less favourable for young women than for men
and for older women.
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